| scholarly article | Q13442814 |
| P50 | author | Daniel Hasche | Q85642440 |
| P2093 | author name string | Frank Rösl | |
| Sabrina E Vinzón | |||
| P2860 | cites work | Screening out irrelevant cell-based models of disease. | Q50479880 |
| Human papillomavirus load in eyebrow hair follicles and risk of cutaneous squamous cell carcinoma. | Q50484146 | ||
| Prevalence and associated factors of betapapillomavirus infections in individuals without cutaneous squamous cell carcinoma. | Q50598757 | ||
| European Code against Cancer 4th Edition: Infections and Cancer. | Q50936040 | ||
| Warts in primary schoolchildren: prevalence and relation with environmental factors. | Q51830513 | ||
| The E7 protein of cutaneous human papillomavirus type 8 causes invasion of human keratinocytes into the dermis in organotypic cultures of skin. | Q52563291 | ||
| Xeroderma Pigmentosum. | Q52880750 | ||
| Loss of p53 or p73 in human papillomavirus type 38 E6 and E7 transgenic mice partially restores the UV-activated cell cycle checkpoints. | Q53515349 | ||
| Keratoacanthoma and squamous cell carcinoma are distinct from a molecular perspective. | Q53610703 | ||
| [Actinic keratosis, Bowen's disease, keratoacanthoma and squamous cell carcinoma of the skin]. | Q53622489 | ||
| The BRAF Inhibitor Vemurafenib Enhances UV-Induced Skin Carcinogenesis in Beta HPV38 E6 and E7 Transgenic Mice. | Q53754882 | ||
| RAS mutations in benign epithelial tumors associated with BRAF inhibitor treatment of melanoma. | Q54331173 | ||
| E6 and E7 from beta HPV38 cooperate with ultraviolet light in the development of actinic keratosis-like lesions and squamous cell carcinoma in mice | Q21089610 | ||
| Protective vaccination against papillomavirus-induced skin tumors under immunocompetent and immunosuppressive conditions: a preclinical study using a natural outbred animal model | Q21131365 | ||
| Drug development: Raise standards for preclinical cancer research | Q22348097 | ||
| Development of AAVLP(HPV16/31L2) particles as broadly protective HPV vaccine candidate | Q24288709 | ||
| Systematic reviews of animal models: methodology versus epistemology | Q24629614 | ||
| Role of Zn2+ ions in host-virus interactions | Q24656940 | ||
| Sequence-based identification of microbial pathogens: a reconsideration of Koch's postulates | Q24669589 | ||
| The epithelial-mesenchymal transition: new insights in signaling, development, and disease | Q24683758 | ||
| DNA Damage Response and Immune Defense: Links and Mechanisms | Q26739398 | ||
| The EVER genes - the genetic etiology of carcinogenesis in epidermodysplasia verruciformis and a possible role in non-epidermodysplasia verruciformis patients | Q26747402 | ||
| Cancer Evolution and the Limits of Predictability in Precision Cancer Medicine | Q26767415 | ||
| Translational Medicine Guide transforms drug development processes: the recent Merck experience | Q26771555 | ||
| From Gene Targeting to Genome Editing: Transgenic animals applications and beyond | Q26781859 | ||
| Evolutionary determinants of cancer | Q26801710 | ||
| Development of skin tumors in mice transgenic for early genes of human papillomavirus type 8. | Q42474839 | ||
| Epidemiology of keratinocyte carcinomas after organ transplantation | Q42516595 | ||
| Seroreactivity to cutaneous human papillomaviruses among patients with nonmelanoma skin cancer or benign skin lesions | Q42523670 | ||
| The Mastomys natalensis papillomavirus: nucleotide sequence, genome organization, and phylogenetic relationship of a rodent papillomavirus involved in tumorigenesis of cutaneous epithelia | Q42611860 | ||
| Complexity in biology. Exceeding the limits of reductionism and determinism using complexity theory | Q42785846 | ||
| Beta-papillomavirus DNA loads in hair follicles of immunocompetent people and organ transplant recipients | Q43428036 | ||
| Cutaneous wart-associated HPV types: prevalence and relation with patient characteristics. | Q43664847 | ||
| Vemurafenib and radiosensitization. | Q43840156 | ||
| Virus-like particles and capsomeres are potent vaccines against cutaneous alpha HPVs | Q44084905 | ||
| Loss of Genome Fidelity: Beta HPVs and the DNA Damage Response | Q45393476 | ||
| Skin tumor formation in human papillomavirus 8 transgenic mice is associated with a deregulation of oncogenic miRNAs and their tumor suppressive targets | Q45790493 | ||
| Tumour induction in the rodent Mastomys natalensis by activation of endogenous papilloma virus genomes | Q45796941 | ||
| Rodent Papillomaviruses. | Q46251800 | ||
| Ultraviolet irradiation induces keratinocyte proliferation and epidermal hyperplasia through the activation of the epidermal growth factor receptor | Q46669839 | ||
| Induction of Tyrosine Phosphorylation of UV-Activated EGFR by the Beta-Human Papillomavirus Type 8 E6 Leads to Papillomatosis | Q46756117 | ||
| The interplay of UV and cutaneous papillomavirus infection in skin cancer development | Q47098228 | ||
| The full transcription map of mouse papillomavirus type 1 (MmuPV1) in mouse wart tissues. | Q47111581 | ||
| Association of papillomavirus E6 proteins with either MAML1 or E6AP clusters E6 proteins by structure, function, and evolutionary relatedness | Q47251663 | ||
| Minor capsid protein L2 polytope induces broad protection against oncogenic and mucosal human papillomaviruses | Q47322093 | ||
| Beta HPV38 oncoproteins act with a hit-and-run mechanism in ultraviolet radiation-induced skin carcinogenesis in mice. | Q47555189 | ||
| A Novel Actinic Keratosis Field Assessment Scale for Grading Actinic Keratosis Disease Severity | Q50251404 | ||
| Human Papillomaviruses; Epithelial Tropisms, and the Development of Neoplasia | Q26801768 | ||
| Skin cancer in organ transplant recipients: effects of immunosuppressive medications on DNA repair | Q26822549 | ||
| Cutaneous manifestations of human papillomaviruses: a review | Q26825551 | ||
| Skin cancer in solid organ transplant recipients: are mTOR inhibitors a game changer? | Q26851436 | ||
| A systematic review of worldwide incidence of nonmelanoma skin cancer | Q26998882 | ||
| Role of Ultraviolet Radiation in Papillomavirus-Induced Disease | Q27313673 | ||
| Preclinical mouse cancer models: a maze of opportunities and challenges | Q27322080 | ||
| Strain-specific properties and T cells regulate the susceptibility to papilloma induction by Mus musculus papillomavirus 1 | Q27324289 | ||
| Mutational landscape of aggressive cutaneous squamous cell carcinoma | Q27853082 | ||
| Interpreting cancer genomes using systematic host network perturbations by tumour virus proteins | Q28117120 | ||
| Of mice and not men: differences between mouse and human immunology | Q28246229 | ||
| Concatenated multitype L2 fusion proteins as candidate prophylactic pan-human papillomavirus vaccines | Q28246307 | ||
| VLPs displaying a single L2 epitope induce broadly cross-neutralizing antibodies against human papillomavirus | Q28280059 | ||
| The virome in mammalian physiology and disease | Q28660380 | ||
| A pan-HPV vaccine based on bacteriophage PP7 VLPs displaying broadly cross-neutralizing epitopes from the HPV minor capsid protein, L2 | Q28741364 | ||
| Papillomaviruses and cancer: from basic studies to clinical application | Q29614745 | ||
| The p53 pathway: positive and negative feedback loops | Q29617535 | ||
| Classification of papillomaviruses | Q29618731 | ||
| Skin cancer concerns particular to women | Q30234504 | ||
| Speculations on the clinical significance of asymptomatic viral infections | Q30248817 | ||
| Microbiology, philosophy and education | Q30391071 | ||
| Cutaneous papillomavirus E6 oncoproteins associate with MAML1 to repress transactivation and NOTCH signaling | Q30419809 | ||
| Human papillomavirus community in healthy persons, defined by metagenomics analysis of human microbiome project shotgun sequencing data sets | Q30756107 | ||
| Control of HPV-associated tumors by innovative therapeutic HPV DNA vaccine in the absence of CD4+ T cells | Q33589738 | ||
| Impact of inhibitors and L2 antibodies upon the infectivity of diverse alpha and beta human papillomavirus types | Q33591582 | ||
| Epidemiological trends in skin cancer | Q33655972 | ||
| Identification of C/EBPα as a novel target of the HPV8 E6 protein regulating miR-203 in human keratinocytes. | Q33825575 | ||
| Papillomavirus pseudovirus: a novel vaccine to induce mucosal and systemic cytotoxic T-lymphocyte responses | Q33847557 | ||
| Transcriptome sequencing demonstrates that human papillomavirus is not active in cutaneous squamous cell carcinoma | Q33872079 | ||
| Genetically engineered mouse models in cancer research | Q36497718 | ||
| Protection against heterologous human papillomavirus challenge by a synthetic lipopeptide vaccine containing a broadly cross-neutralizing epitope of L2. | Q36545925 | ||
| NOTCH1 mutations occur early during cutaneous squamous cell carcinogenesis | Q36580224 | ||
| Genetics of epidermodysplasia verruciformis: Insights into host defense against papillomaviruses | Q36608599 | ||
| Key considerations and current perspectives of epidemiological studies on human papillomavirus persistence, the intermediate phenotype to cervical cancer | Q36698833 | ||
| Differential expression of miR-1, a putative tumor suppressing microRNA, in cancer resistant and cancer susceptible mice | Q36812809 | ||
| Nevoid Basal Cell Carcinoma Syndrome (Gorlin Syndrome) | Q36819990 | ||
| Beta-catenin and ZO-1: shuttle molecules involved in tumor invasion-associated epithelial-mesenchymal transition processes | Q36857764 | ||
| Protective role of p53 in skin cancer: Carcinogenesis studies in mice lacking epidermal p53. | Q37190476 | ||
| Serological relationship between cutaneous human papillomavirus types 5, 8 and 92 | Q37226380 | ||
| The EVER proteins as a natural barrier against papillomaviruses: a new insight into the pathogenesis of human papillomavirus infections | Q37232535 | ||
| Expression of betapapillomavirus oncogenes increases the number of keratinocytes with stem cell-like properties | Q37254338 | ||
| Human papillomavirus molecular biology and disease association | Q37257349 | ||
| Molecular concepts of virus infections causing skin cancer in organ transplant recipients | Q37266570 | ||
| Efficacy of RG1-VLP vaccination against infections with genital and cutaneous human papillomaviruses. | Q37306139 | ||
| Betapapillomaviruses: innocent bystanders or causes of skin cancer | Q37318413 | ||
| Characterization of Mus musculus papillomavirus 1 infection in situ reveals an unusual pattern of late gene expression and capsid protein localization | Q37336676 | ||
| Chimeric L1-L2 virus-like particles as potential broad-spectrum human papillomavirus vaccines | Q37356046 | ||
| Gene Expression Architecture of Mouse Dorsal and Tail Skin Reveals Functional Differences in Inflammation and Cancer. | Q37381860 | ||
| Immunogenicity of an HPV-16 L2 DNA vaccine | Q37399767 | ||
| Cohort profile: the skin cancer after organ transplant study | Q37460839 | ||
| Tumour suppression by p53: the importance of apoptosis and cellular senescence | Q37534605 | ||
| Immunosuppression facilitates the reactivation of latent papillomavirus infections | Q37547649 | ||
| Apoptosis and autophagy: Regulation of apoptosis by DNA damage signalling - roles of p53, p73 and HIPK2. | Q37605156 | ||
| Cutaneous HPV8 and MmuPV1 E6 Proteins Target the NOTCH and TGF-β Tumor Suppressors to Inhibit Differentiation and Sustain Keratinocyte Proliferation. | Q37619334 | ||
| Paradoxical oncogenesis--the long-term effects of BRAF inhibition in melanoma | Q37697778 | ||
| The cancer cell map initiative: defining the hallmark networks of cancer | Q37712293 | ||
| The hair follicle-a stem cell zoo. | Q37718998 | ||
| Human papillomavirus oncoproteins: pathways to transformation | Q37769103 | ||
| p53 and its mutants in tumor cell migration and invasion | Q37832072 | ||
| The consequences of UV-induced immunosuppression for human health | Q37900330 | ||
| Understanding and learning from the success of prophylactic human papillomavirus vaccines. | Q38041983 | ||
| The biology and life-cycle of human papillomaviruses. | Q38064068 | ||
| Cutaneous toxicities of RAF inhibitors. | Q38070436 | ||
| Keratoacanthoma clinical behavior: a systematic review | Q38173658 | ||
| The E6 and E7 proteins of the cutaneous human papillomavirus type 38 display transforming properties | Q39699774 | ||
| Potent anti-HPV immune responses induced by tandem repeats of the HPV16 L2 (20 -- 38) peptide displayed on bacterial thioredoxin | Q39860799 | ||
| E6 proteins from multiple human betapapillomavirus types degrade Bak and protect keratinocytes from apoptosis after UVB irradiation | Q39948840 | ||
| The Mouse Papillomavirus Infection Model. | Q40059688 | ||
| UV Radiation Activates Toll-Like Receptor 9 Expression in Primary Human Keratinocytes, an Event Inhibited by Human Papillomavirus 38 E6 and E7 Oncoproteins | Q40127489 | ||
| Localization of papillomavirus and virus-specific antigens in the skin of tumor-bearingMastomys natalensis (GRA Giessen) | Q40161410 | ||
| HPV8 Field Cancerization in a Transgenic Mouse Model Is due to Lrig1+ Keratinocyte Stem Cell Expansion | Q40166929 | ||
| Mastomys natalensis Papilloma Virus (MnPV), the Causative Agent of Epithelial Proliferations: Characterization of the Virus Particle | Q40190291 | ||
| The levels of epithelial anchor proteins β-catenin and zona occludens-1 are altered by E7 of human papillomaviruses 5 and 8. | Q40234525 | ||
| Clinicopathologic features of skin cancer in organ transplant recipients: a retrospective case-control series. | Q40354945 | ||
| Role of Bak in UV-induced apoptosis in skin cancer and abrogation by HPV E6 proteins | Q40445624 | ||
| Lipidated L2 epitope repeats fused with a single-chain antibody fragment targeting human FcγRI elicited cross-neutralizing antibodies against a broad spectrum of human papillomavirus types | Q40490973 | ||
| Transcriptome analysis of Mastomys natalensis papillomavirus in productive lesions after natural infection | Q40729412 | ||
| Novel ß-HPV49 Transgenic Mouse Model of Upper Digestive Tract Cancer | Q40740019 | ||
| Human papillomavirus infection and non-melanoma skin cancer in immunosuppressed and immunocompetent individuals. | Q40760209 | ||
| Secretory production of designed multipeptides displayed on a thermostable bacterial thioredoxin scaffold in Pichia pastoris | Q40773802 | ||
| Trends of skin cancer mortality after transplantation in the United States: 1987 to 2013. | Q40806299 | ||
| The fibronectin/α3β1 integrin axis serves as molecular basis for keratinocyte invasion induced by βHPV. | Q40954858 | ||
| Tumor suppressor identity can contribute to heterogeneity of phenotype in hair follicle stem cell-induced squamous cell carcinoma. | Q40961215 | ||
| Cancer Mortality Among Recipients of Solid-Organ Transplantation in Ontario, Canada | Q40990219 | ||
| The oncogenic potential of herpes simplex viruses: evidence for a ‘hit-and-run’ mechanism | Q41555454 | ||
| Cutaneous warts | Q41561113 | ||
| ‘Hit and run’ oncogenesis by human papillomavirus type 18 DNA | Q41633365 | ||
| Human papillomavirus 16L1-58L2 chimeric virus-like particles elicit durable neutralizing antibody responses against a broad-spectrum of human papillomavirus types | Q41926367 | ||
| Mouse papillomavirus infections spread to cutaneous sites with progression to malignancy | Q41931149 | ||
| Why Human Papillomaviruses Activate the DNA Damage Response (DDR) and How Cellular and Viral Replication Persists in the Presence of DDR Signaling | Q41932983 | ||
| Tumor prevention in HPV8 transgenic mice by HPV8-E6 DNA vaccination | Q42242199 | ||
| Improved detection reveals active β-papillomavirus infection in skin lesions from kidney transplant recipients | Q42245249 | ||
| On the limitations of biological knowledge | Q42430005 | ||
| Non-melanoma skin cancer incidence and impact of skin cancer screening on incidence. | Q42441842 | ||
| The influence of painful sunburns and lifetime sun exposure on the risk of actinic keratoses, seborrheic warts, melanocytic nevi, atypical nevi, and skin cancer | Q42442425 | ||
| HIPK2 expression in progression of cutaneous epithelial neoplasm | Q42473331 | ||
| Molecular Koch's postulates applied to bacterial pathogenicity--a personal recollection 15 years later | Q35701614 | ||
| Tumor evolution. High burden and pervasive positive selection of somatic mutations in normal human skin | Q35752935 | ||
| Immunologic Control of Mus musculus Papillomavirus Type 1. | Q35818624 | ||
| HPV vaccination for prevention of skin cancer | Q35887782 | ||
| HIPK2 represses beta-catenin-mediated transcription, epidermal stem cell expansion, and skin tumorigenesis | Q35919080 | ||
| Photocarcinogenesis and Skin Cancer Prevention Strategies | Q35957001 | ||
| Immunizing against Anogenital Cancer: HPV Vaccines | Q36022468 | ||
| Establishment of an Immortalized Skin Keratinocyte Cell Line Derived from the Animal Model Mastomys coucha. | Q36105931 | ||
| Cross-species identification of genomic drivers of squamous cell carcinoma development across preneoplastic intermediates. | Q36116513 | ||
| Cancer associated human papillomaviruses | Q36173879 | ||
| The CXCL12/CXCR4 Signaling Pathway: A New Susceptibility Factor in Human Papillomavirus Pathogenesis | Q36213484 | ||
| The Papillomavirus Episteme: a major update to the papillomavirus sequence database | Q36239822 | ||
| Chimeric L2-Based Virus-Like Particle (VLP) Vaccines Targeting Cutaneous Human Papillomaviruses (HPV) | Q36240497 | ||
| Common Commensal Cancer Viruses | Q36254085 | ||
| Cancer in rodents: does it tell us about cancer in humans? | Q36272962 | ||
| A protective and broadly cross-neutralizing epitope of human papillomavirus L2. | Q36315086 | ||
| Dissecting complex disease: the quest for the Philosopher's Stone? | Q36422614 | ||
| Warts and all: human papillomavirus in primary immunodeficiencies | Q36455030 | ||
| Generation and characterization of a preventive and therapeutic HPV DNA vaccine | Q36482161 | ||
| Human papillomavirus-associated diseases | Q38190128 | ||
| Role of human papillomavirus in cutaneous squamous cell carcinoma: a meta-analysis. | Q38195964 | ||
| MicroRNAs and p63 in epithelial stemness. | Q38244285 | ||
| Seroprevalence of cutaneous human papillomaviruses (HPVs) among men in the multinational HPV Infection in Men study | Q38377027 | ||
| The Promise of Genomics and the Development of Targeted Therapies for Cutaneous Squamous Cell Carcinoma | Q38530398 | ||
| "Hit-and-Run" leaves its mark: catalyst transcription factors and chromatin modification. | Q38537226 | ||
| Model systems of human papillomavirus-associated disease | Q38604326 | ||
| Emerging bacterial pathogens: the past and beyond | Q38614324 | ||
| Incorporation of RG1 epitope concatemers into a self-adjuvanting Flagellin-L2 vaccine broaden durable protection against cutaneous challenge with diverse human papillomavirus genotypes | Q38640038 | ||
| Human papillomavirus 16 E6 and E7 oncoprotein expression alters microRNA expression in extracellular vesicles | Q38703619 | ||
| The DNA damage-induced cell death response: a roadmap to kill cancer cells | Q38704734 | ||
| Human papillomavirus first and second generation vaccines-current status and future directions | Q38741626 | ||
| Wounding induces dedifferentiation of epidermal Gata6+ cells and acquisition of stem cell properties | Q38786073 | ||
| Repair of UV-induced thymine dimers is compromised in cells expressing the E6 protein from human papillomaviruses types 5 and 18. | Q38795632 | ||
| Keratinocyte Carcinoma as a Marker of a High Cancer-Risk Phenotype | Q38796191 | ||
| The epithelial-mesenchymal transition (EMT) is regulated by oncoviruses in cancer | Q38859750 | ||
| CONSENSUS REPORT: Recognizing non-melanoma skin cancer, including actinic keratosis, as an occupational disease - A Call to Action. | Q38892821 | ||
| Association Between β-Genus Human Papillomavirus and Cutaneous Squamous Cell Carcinoma in Immunocompetent Individuals-A Meta-analysis | Q38925856 | ||
| Resistance to UV-induced apoptosis by β-HPV5 E6 involves targeting of activated BAK for proteolysis by recruitment of the HERC1 ubiquitin ligase. | Q38939325 | ||
| Non-genetic risk factors for cutaneous melanoma and keratinocyte skin cancers: An umbrella review of meta-analyses | Q38963005 | ||
| Transgenic Mouse Models of Tumor Virus Action | Q38980707 | ||
| Tumor evolution: Linear, branching, neutral or punctuated? | Q39007635 | ||
| Developments in L2-based human papillomavirus (HPV) vaccines | Q39021001 | ||
| UV-B irradiation stimulates the promoter activity of the high-risk, cutaneous human papillomavirus 5 and 8 in primary keratinocytes | Q39030101 | ||
| Crosstalk Among UV-Induced Inflammatory Mediators, DNA Damage and Epigenetic Regulators Facilitates Suppression of the Immune System | Q39034042 | ||
| Recent advances in preclinical model systems for papillomaviruses | Q39036718 | ||
| Advances in histopathological diagnosis of keratoacanthoma | Q39159797 | ||
| HPV-transgenic mouse models: Tools for studying the cancer-associated immune response. | Q39225062 | ||
| Secreted molecules inducing epithelial-to-mesenchymal transition in cancer development. | Q39412285 | ||
| Characterization of beta papillomavirus E4 expression in tumours from Epidermodysplasia Verruciformis patients and in experimental models | Q39417822 | ||
| Molecular Mechanisms of Human Papillomavirus Induced Skin Carcinogenesis | Q39434895 | ||
| Prospective study of human papillomavirus seropositivity and risk of nonmelanoma skin cancer | Q39640644 | ||
| Cutaneous papillomavirus E6 proteins must interact with p300 and block p53-mediated apoptosis for cellular immortalization and tumorigenesis. | Q39675073 | ||
| Spontaneous and Vaccine-Induced Clearance of Mus Musculus Papillomavirus 1 Infection | Q33907700 | ||
| Host-pathogen interactions: basic concepts of microbial commensalism, colonization, infection, and disease | Q33925636 | ||
| Deep sequencing extends the diversity of human papillomaviruses in human skin. | Q33941956 | ||
| Genetic determinants of UV-susceptibility in non-melanoma skin cancer | Q33961402 | ||
| Beta-HPV 5 and 8 E6 promote p300 degradation by blocking AKT/p300 association | Q34013630 | ||
| Genus beta human papillomavirus E6 proteins vary in their effects on the transactivation of p53 target genes. | Q34057911 | ||
| Cutaneous HPV23 E6 prevents p53 phosphorylation through interaction with HIPK2. | Q34081681 | ||
| Viral hit and run-oncogenesis: Genetic and epigenetic scenarios | Q34135741 | ||
| Natural history of cutaneous human papillomavirus (HPV) infection in men: the HIM study | Q34149686 | ||
| Causality in medicine: the case of tumours and viruses | Q34155340 | ||
| Criteria for etiologic association of prevalent viruses with prevalent diseases; the virologist's dilemma | Q34240938 | ||
| EVER proteins, key elements of the natural anti-human papillomavirus barrier, are regulated upon T-cell activation | Q34326712 | ||
| Mastomys natalensis or Mastomys coucha. Correct species designation in animal experiments. | Q34355096 | ||
| Human papillomavirus type 8 interferes with a novel C/EBPβ-mediated mechanism of keratinocyte CCL20 chemokine expression and Langerhans cell migration. | Q34387292 | ||
| Suppression of Langerhans cell activation is conserved amongst human papillomavirus α and β genotypes, but not a µ genotype | Q34408919 | ||
| Viral metagenomics | Q34417786 | ||
| Human papillomavirus-DNA loads in actinic keratoses exceed those in non-melanoma skin cancers | Q34429330 | ||
| Histopathological variants of cutaneous squamous cell carcinoma: a review | Q34479227 | ||
| The human skin double-stranded DNA virome: topographical and temporal diversity, genetic enrichment, and dynamic associations with the host microbiome. | Q34498930 | ||
| Opposing roles for calcineurin and ATF3 in squamous skin cancer | Q34632548 | ||
| Immune status, strain background, and anatomic site of inoculation affect mouse papillomavirus (MmuPV1) induction of exophytic papillomas or endophytic trichoblastomas | Q34634389 | ||
| Principia aetiologica: taking causality beyond Koch's postulates | Q34707344 | ||
| Epidemiology of melanoma and nonmelanoma skin cancer--the role of sunlight. | Q34762654 | ||
| UV signature mutations | Q34963798 | ||
| Expression of human skin-specific genes defined by transcriptomics and antibody-based profiling | Q35009795 | ||
| General acquisition of human papillomavirus infections of skin occurs in early infancy | Q35026612 | ||
| Use of viral infections in animal models to assess changes in the immune system | Q35036329 | ||
| Vemurafenib cooperates with HPV to promote initiation of cutaneous tumors | Q35093447 | ||
| Low doses of flagellin-L2 multimer vaccines protect against challenge with diverse papillomavirus genotypes | Q35095954 | ||
| Skin cancers after organ transplantation | Q35113533 | ||
| Prospects for personalized targeted therapies for cutaneous squamous cell carcinoma | Q35217649 | ||
| Roles of the immune system in skin cancer. | Q35403714 | ||
| Dialogue between skin microbiota and immunity | Q35441353 | ||
| From keratinocyte to cancer: the pathogenesis and modeling of cutaneous squamous cell carcinoma | Q35698913 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P921 | main subject | skin cancer | Q192102 |
| P304 | page(s) | 874 | |
| P577 | publication date | 2018-05-02 | |
| P1433 | published in | Frontiers in Microbiology | Q27723481 |
| P1476 | title | Cutaneous Papillomaviruses and Non-melanoma Skin Cancer: Causal Agents or Innocent Bystanders? | |
| P478 | volume | 9 |
| Q100634459 | ATP synthase modulation leads to an increase of spare respiratory capacity in HPV associated cancers |
| Q90379244 | Cancer susceptibility of beta HPV49 E6 and E7 transgenic mice to 4-nitroquinoline 1-oxide treatment correlates with mutational signatures of tobacco exposure |
| Q90721452 | Detection of human papillomaviruses in paired healthy skin and actinic keratosis by next generation sequencing |
| Q98195668 | Expression of different L1 isoforms of Mastomys natalensis papillomavirus as mechanism to circumvent adaptive immunity |
| Q98895322 | Human papillomavirus 16-positive supraclavicular cutaneous squamous cell carcinoma metastatic to the level IV supraclavicular lymph nodes |
| Q59351571 | More than just oncogenes: mechanisms of tumorigenesis by human viruses |
| Q64122345 | Species as Model Systems for Infectious Diseases |
| Q64092342 | The Protein Tyrosine Phosphatase H1 PTPH1 Supports Proliferation of Keratinocytes and is a Target of the Human Papillomavirus Type 8 E6 Oncogene |
| Q64239781 | Viral genome integration of canine papillomavirus 16 |
| Q98578995 | β-HPV 8E6 combined with TERT expression promotes long-term proliferation and genome instability after cytokinesis failure |
Search more.